PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ipratropium bromide - Respiratory disease indications
PAD Profile : Ipratropium bromide - Respiratory disease indications
Keywords :
COPD, severe acute asthma, reversible airways obstruction, bronchospasm
Brand Names Include :
Atrovent
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Methotrexate
- Azathioprine
- Mycophenolate mofetil
- Leflunomide
- Salbutamol
- Terbutaline sulphate
- Salbutamol
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
03. Respiratory System
03.01.02. Antimuscarinic bronchodilators